Does Insurance Cover Wegovy or Zepbound for Weight Loss?

The Short Answer

• Commercial or employer insurance: depends on your plan. Many plans exclude weight-loss drugs; others cover them with prior authorization. If yours covers them, manufacturer savings programs can cut the copay to as little as $25.
• Medicare: Part D plans have generally not covered drugs for weight loss alone, but the Medicare GLP-1 Bridge (July 1, 2026 to the end of 2027) lets eligible enrollees get Wegovy, Zepbound KwikPen or Foundayo for a $50 monthly copay.
• Medicaid: depends on your state. KFF counted 13 state programs covering GLP-1s for obesity in January 2026.

Commercial and Employer Insurance

Your plan's drug list (formulary) decides coverage. Some employers buy coverage for weight-loss medications and some don't. When a plan covers them, it usually requires prior authorization showing you meet the FDA-approved criteria, such as a body mass index of 30 or more, or 27 or more with a weight-related condition.

• Wegovy: with commercial coverage, the Wegovy savings offer can bring the cost to as little as $25 a month (maximum savings $100 a month).
• Zepbound: the savings card can bring the cost to as little as $25 with coverage; it expires December 31, 2026. Lilly says coverage was restored on select CVS Caremark formularies.
• Foundayo: commercially insured patients with coverage could pay as little as $25 a month.
• No coverage? Both companies offer separate self-pay prices (Wegovy pen $349 a month, Zepbound $449 at maintenance, Foundayo and Wegovy pill from $149).

How to check your coverage

1. Search your insurer's formulary for Wegovy, Zepbound and Foundayo, or call the number on your card and ask whether weight-management drugs are covered and whether prior authorization is required.
2. Use the manufacturers' coverage tools on novocare.com and zepbound.lilly.com.
3. Ask HR whether your employer plan excludes weight-loss medication; it is a plan design choice.

Medicare

Part D plans have generally excluded drugs used only for weight loss, but they can cover GLP-1s for other approved uses, such as type 2 diabetes, Wegovy to reduce cardiovascular risk in people with heart disease, or Zepbound for obstructive sleep apnea.

The Medicare GLP-1 Bridge runs from July 1, 2026 through the end of 2027. Eligible enrollees pay a $50 monthly copay for Wegovy (injection or pill), Foundayo or the Zepbound KwikPen. According to AARP's summary, you must be 18 or older, be enrolled in an eligible Part D plan, not already have a covered indication, and meet BMI criteria when you start: a BMI of 35 or more; 30 or more with stage 3a or higher chronic kidney disease, heart failure with preserved ejection fraction or uncontrolled high blood pressure; or 27 or more with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. The program operates outside Part D plan coverage.

Medicaid

Coverage varies by state. KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service in January 2026, and noted that several states, including California, New Hampshire, Pennsylvania and South Carolina, dropped coverage. Federal policy is changing too: the administration announced pricing agreements with Novo Nordisk and Eli Lilly in November 2025, and CMS introduced the BALANCE model in December 2025 to expand access in Medicaid and Medicare.

If You're Denied

1. Ask why. A denial may be a plan exclusion (hard to overturn) or a missing prior-authorization detail (often fixable).
2. Ask your prescriber to resubmit with documentation: BMI history, related conditions and previous weight-loss attempts.
3. Use the formal appeal process; your plan must explain it in the denial letter.
4. Compare self-pay options: manufacturer prices, compounded programs and HSA/FSA funds, which can usually be used for prescribed medication.

Telehealth Programs That Work With Insurance

Several programs handle insurance checks and prior authorization for you, including Ro, Found, Calibrate, Mochi Health and WeightWatchers Clinic. They charge a membership for that service; see each review for current fees.